Current Cancer Drug Targets

Editor-in-Chief:

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA

Back

EDITORIAL [Hot Topic: Molecularly Targeted Treatments for Colorectal Cancer: Advances and Limitations (Guest Editor: Silvio Parodi)] promotion: free to download

Volume:12   Issue:4
Pp: 301-302
Silvio Parodi
DOI: 10.2174/156800912800190947

Role of Angiogenesis Inhibitors in Colorectal Cancer: Sensitive and Insensitive Tumors

Volume:12   Issue:4
Pp: 303-315
L. Bagnasco, D. Piras, S. Parodi, I. Bauer, G. Zoppoli, F. Patrone and A. Ballestrero
DOI: 10.2174/156800912800190929

Patient-Tailored Treatments with Anti-EGFR Monoclonal Antibodies in Advanced Colorectal Cancer: KRAS and Beyond

Volume:12   Issue:4
Pp: 316-328
A. Ballestrero, A. Garuti, G. Cirmena, I. Rocco, C. Palermo, A. Nencioni, S. Scabini, G. Zoppoli, S. Parodi and F. Patrone
DOI: 10.2174/156800912800190956

Synthetic Lethality-Based Therapeutics: Perspectives for Applications in Colorectal Cancer

Volume:12   Issue:4
Pp: 329-338
D. Soncini, I. Caffa, F. Patrone, A. Ballestrero and A. Nencioni
DOI: 10.2174/156800912800190938

Genetic Variants in Genes Involved in Mechanisms of Chemoresistance to Anticancer Drugs open access plus

Volume:12   Issue:4
Pp: 402-438
J. J.G. Marin, O. Briz, M. J. Monte, A. G. Blazquez and R. I.R. Macias
DOI: 10.2174/156800912800190875

An Epigenetic Approach to Pancreatic Cancer Treatment: The Prospective Role of Histone Deacetylase Inhibitors open access plus

Volume:12   Issue:4
Pp: 439-452
Nicola Tinari, Michele De Tursi, Antonino Grassadonia, Marinella Zilli, Liborio Stuppia, Stefano Iacobelli and Clara Natoli
DOI: 10.2174/156800912800190884